scholarly journals A Case of Obturator Foramen Bypass for Infected Femoral Artery after Use of an Arterial Closure Device

2003 ◽  
Vol 32 (6) ◽  
pp. 370-373
Author(s):  
Shin Uchikawa ◽  
Noboru Murata ◽  
Kazuhide Hayashi
Keyword(s):  
Femoral Artery ◽  
Closure Device ◽  
Obturator Foramen ◽  
Arterial Closure Device

Obturator foramen bypass for infective groin caused by closure device

2016 ◽  
Vol 25 (2) ◽  
pp. 131-133
Author(s):  
Yoshihito Irie ◽  
Shunichi Kondo ◽  
Kyu Rokkaku ◽  
Eitoshi Tsuboi ◽  
Hiroshi Takano ◽  
...  
Keyword(s):  
Femoral Artery ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Wound Irrigation ◽  
Obturator Foramen ◽  
Artery Pseudoaneurysm ◽  
The Right ◽  
And Control ◽  
Patch Plasty ◽  
Leg Ischemia

A 69-year-old man underwent carotid artery stenting through the right femoral artery with a percutaneous vascular closure device for hemostasis. Eleven days later, an infective femoral artery pseudoaneurysm was diagnosed by computed tomography. At surgery, a defect in the femoral artery was observed, corresponding to the remnants of the closure device. Removal of the foreign material, debridement, wound irrigation, and arterial patch plasty were performed, but the infection and leg ischemia did not improve. After several failed attempts to revascularize and control the infection, obturator foramen bypass was performed. The postoperative course was uneventful, indicating the usefulness of this procedure.

Closure device use for common femoral artery antegrade access is higher risk than retrograde access

2021 ◽  
Author(s):  
Joel L. Ramirez ◽  
Eric J.T. Smith ◽  
Devin S. Zarkowsky ◽  
Jose Lopez ◽  
Caitlin W. Hicks ◽  
...  
Keyword(s):  
Femoral Artery ◽  
Common Femoral Artery ◽  
Closure Device ◽  
Device Use

scholarly journals Treatment of Infected Pseudoaneurysm of Femoral Artery after Vascular Closure Device Deployment: A Practical Solution

2012 ◽  
Vol 2012 ◽  
pp. 1-4
Author(s):  
Predrag Matic ◽  
Srdjan Babic ◽  
Slobodan Tanaskovic ◽  
Dario Jocic ◽  
Djordje Radak
Keyword(s):  
Femoral Artery ◽  
Arterial Occlusion ◽  
Surgical Excision ◽  
Common Femoral Artery ◽  
Coronary Intervention ◽  
Closure Device ◽  
Arteriovenous Fistulas ◽  
Percutaneous Coronary ◽  
Infected Pseudoaneurysm ◽  
Device Deployment

Like other invasive procedures, percutaneous coronary interventions are associated with complications. Most common access site for these procedures is common femoral artery. Complications such as groin and retroperitoneal hematoma can be encountered as well as pseudoaneurysms, arteriovenous fistulas, acute arterial occlusion, and infection. When infected pseudoaneurysm occurs, surgical treatment can be extremely difficult. We present a case of the patient in whom infected pseudoaneurysm of common femoral artery developed after percutaneous coronary intervention and was successfully treated by surgical excision and autoarterial graft insertion.

Use of the VASCADE Arterial Closure Device to Achieve Hemostasis after a Deep Venous Procedure

2015 ◽  
Vol 26 (9) ◽  
pp. 1409-1410 ◽  
Author(s):  
Timo O. Tondelli ◽  
Ronald S. Winokur ◽  
Akhilesh K. Sista
Keyword(s):  
Closure Device ◽  
Arterial Closure Device

Vascular closure devices in TAVI: MANTA versus ProGlide in a propensity-matched population

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
G Sa Mendes ◽  
A Oliveira ◽  
R Campante Teles ◽  
P Araujo Goncalves ◽  
J Brito ◽  
...  
Keyword(s):  
Propensity Score ◽  
Learning Curve ◽  
Primary Endpoint ◽  
Femoral Artery ◽  
Statistical Significance ◽  
Vascular Complications ◽  
Artery Stenosis ◽  
Closure Device ◽  
Efficacy And Safety ◽  
Life Threatening

Abstract Background Vascular complications increase morbidity and mortality in transcatheter aortic valve implantation (TAVI). A collagen plug-based closure device - MANTA® was recently introduced as an alternative to the suture-mediated ProGlide® vascular closure device (VCD). Data regarding the efficacy and safety comparing both VCD is scarce. The present study sought to compare the effectiveness of both devices. Methods Single center retrospective analysis on prospectively collected data of 300 consecutive patients who underwent TAVI using MANTA® or ProGlide® since 2018. A 1:1 propensity-score matched population derived by a multivariate logistic regression model based on age, sex, body mass index, pre-procedural haemoglobin, EuroSCORE II, main access calcification and the sheath-to-artery ratio. The primary endpoint was the composite of major or life-threatening bleeding (VARC-2 definition), femoral artery stenosis/dissection, pseudoaneurysm and need for endovascular/surgical bailout intervention. Results The propensity score matching resulted in 129 matched pairs. The median age was 84 years old [IQR 80–87], 42% males with a median EuroSCOREII of 4.29% [IQR 3.05–6.24]. There were no differences in the primary endpoint between MANTA ® and ProGlide® cohorts (3.9% vs 7.8%, p=0.287, respectively). The rates of the primary endpoint with the MANTA® device decreased with center experience, with relatively steep learning curve effect concerning device success. Major or life-threatening bleeding (3.1% vs 5.4%, p=0.540) and pseudoaneurysm (0.8% vs 2.3%, p=0.622) occurred less frequently in MANTA® cohort, but the differences did not reach statistical significance. Endovascular (stent or balloon) or surgical rescue intervention (9.3% vs 5.4%, p=0.341) and femoral artery stenosis/dissection (6.2% vs 3.1%, p=0.376), were also similar rates. In ProGlide® cohort, to achieve VCD success (without primary endpoint events), 15.5% needed more than 2 devices, significantly different from MANTA ® (p<0,001). Conclusions In patients undergoing transfemoral TAVI, the MANTA® VCD showed a similar efficacy and safety compared to the ProGlide® device and it reduced significantly the need of additional VCDs for completion of hemostasis. These results were obtained despite a clear learning curve associated with MANTA. Funding Acknowledgement Type of funding source: None

Sign in / Sign up

Export Citation Format

Share Document